1,222.50 USD
↘ 3.24 (0.26%)PRE MARKET (AS OF 06:35 AM EDT)
Shares of Eli Lilly & Co. (LLY) are trading at $1,222.50. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 18, 2026.
Open?$1,224.74
High?$1,227.84
Low?$1,218.51
Prev. Close?$1,225.73
Volume?5.1K
Avg. Volume?2.6M
VWAP?$1,222.93
Rel. Volume?0.00x
Bid / Ask
Bid?$1,219.47 × 40
Ask?$1,225.00 × 40
Spread?$5.53
Midpoint?$1,222.24
Valuation & Ratios
Market Cap?1092.6B
Shares Out?941.4M
Float?848.8M
Float %?90.1%
P/E Ratio?43.22
P/B Ratio?35.02
EPS?$28.36
Dividend?0.51%
Ex-Dividend?N/A
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1054.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?63
Piotroski F-Score?6/9Mixed
Altman Z-Score?9.73Safe
Confidence?74%Moderate
Short InterestModerate
Short % of Float?1.07%Low
Short Interest?9.1M
Days to Cover?3.9
Free Float848.8M
Avg Daily Volume2.3M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?43.2PRICEY▾
Peers30
S&P16
P/B?35.02HIGH▾
Peers10
S&P3
P/S?15.12HIGH▾
Peers20
S&P3
P/FCF?92.4PRICEY▾
Peers10
S&P3
EV/EBITDA?31.2HIGH▾
Peers20
S&P9
EV/Sales?15.65HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?81.0%STRONG▾
Peers89
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$1130.7B
Fundamentals ratios updated end of day